Swisse purchased for a healthy price

Wilson Asset Management

Wilson Asset Management

Biostime International, a Hong Kong-listed producer of infant formula and milk powder, has purchased 83% of Swisse Wellness for $1.39 billion. The transaction is expected to be funded by the issue of 20.5 million shares and a $450 million bridge loan. Financial metrics related to the transaction have not been released, however we expect the company to provide more information to the market shortly. The sale comes after Swisse competitor Blackmores share price hit $136.78, a rise of almost 290% this year due to surging demand from China. HSBC and ANZ Banking Group helped to fund the deal.

Wilson Asset Management
Wilson Asset Management

Wilson Asset Management has a track record of making a difference for shareholders and the community for more than 20 years. As the investment manager for eight leading LICs – WAM Capital (ASX: WAM), WAM Leaders (ASX: WLE), WAM Global (ASX: WGB),...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Please sign in to comment on this wire.

trending on livewire
Get the best of Livewire by signing up to our popular daily newsletter